home / stock / mpsyf / mpsyf quote
Last: | $71.38 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $71.38 |
High: | $0 |
Low: | $0 |
Volume: | 2 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$71.38 | $0 | $71.38 | $0 | $0 | 2 | 05-16-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 45 | 04-22-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 79 | 03-28-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 74 | 03-27-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 40 | 03-22-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 7,523 | 03-21-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 23 | 03-20-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 1 | 03-19-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 6 | 03-18-2024 |
$71.38 | $0 | $71.38 | $0 | $0 | 8 | 03-15-2024 |
$71.38 | $71.38 | $71.38 | $71.38 | $71.38 | 256 | 03-14-2024 |
$72.71 | $0 | $72.71 | $0 | $0 | 4 | 03-13-2024 |
$72.71 | $72.71 | $72.71 | $72.71 | $72.71 | 108 | 03-12-2024 |
$70.28 | $70.28 | $70.28 | $70.28 | $70.28 | 106 | 02-09-2024 |
$68.5683 | $68.5683 | $68.5683 | $68.5683 | $68.5683 | 102,622 | 02-07-2024 |
$65.69 | $70.659 | $65.69 | $70.659 | $65.69 | 672,056 | 02-06-2024 |
$69.29 | $46 | $69.29 | $69.29 | $45.93 | 19,900 | 02-05-2024 |
$44.4 | $45.57 | $44.4 | $46.21 | $44.4 | 800 | 02-02-2024 |
$45.62 | $44.72 | $45.62 | $45.62 | $44.72 | 300 | 02-01-2024 |
$42.07 | $42.64 | $42.07 | $42.72 | $42.07 | 300 | 01-31-2024 |
News, Short Squeeze, Breakout and More Instantly...
Morphosys Ag Ord Company Name:
MPSYF Stock Symbol:
OTCMKTS Market:
Additional ASCO 2024 poster presentation will include new findings from the Phase 2 study of tulmimetostat PLANEGG and MUNICH, GERMANY / ACCESSWIRE / April 24, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that new efficacy and safety data from the Phase 3 MANIFEST-2 trial of pel...
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billion Shareholders benefit from attractive premium of 94% and 142% on the volume-weighted average price during the last month and three months before January 25, 2024, respectively Acce...
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / March 22, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced the receipt of U.S. antitrust clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") in connection with the proposed acquisition of MorphoSys by Novart...